The Hindu Business Line : Tuesday, May 05, 2009

WEB EXTRAS

RESEARCH & DEVELOPMENT: Ranbaxy close to completing trials for new malaria drug
New Delhi, May 4 Ranbaxy Laboratories Ltd on Monday announced the commencement of the third phase clinical trials for its new anti-malaria combination drug in India, Bangladesh and ...

INFRASTRUCTURE: IDFC Project Equity set to invest $110 m in two projects
Likely to pick up stakes in two infrastructure projects. Mumbai, May 4 IDFC Project Equity Co Ltd, set up by Infrastructure Development Finance Company (IDFC) as an infrastructure equity investment management company, is poised to invest about ...

Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line

Markets (May 04)

Nifty (at close)	3654.00(+180.05)
US Dollar (Buy/Sell)	49.92/94
Brent crude (a bbl) Rs	2,618
Gold (a gram) Rs	1,336
Silver (a kg) Rs	21,685

In Focus
Nano - The People's Car

Mandate 2009

Who is hiring?

More

Other Top Stories
Variable pay component in employees’ compensation packages raised

Capgemini hands out pink slips to 600

Srei Infra promoters hike stake by 5%; skip warrants conversion

Anti-tobacco campaigners cry foul over dilution of health warnings

Cement demand slows down in April

Transaction fee row: NCDEX moves SC

A date with Nano at the shopping mall

Looking back
Apr. 26-May. 2
Tourist arrivals to India to grow

LIC new premium income declines 9.8%

Nasscom to press for STPI benefits

Rejig at Satyam helm after another exit